Serva Health Insights
Welcome to the Serva Health Blog—your destination for insights on patient engagement, clinical trial support, and biopharma commercial services. Our insights are designed to provide valuable information and expert perspectives on how to enhance patient care, streamline clinical trial processes, and navigate the complexities of healthcare. Here, you’ll find articles that explore the latest trends in patient support strategies, innovative healthcare technologies, and best practices for optimizing patient outcomes. Stay informed with Serva Health as we continue to shape the future of healthcare services.
A patient support program can only be as effective as the operating model behind it. Strong patient support program design starts before launch by identifying how patients, healthcare providers, payers, specialty pharmacies, and sites of care will move through the access and treatment journey. The goal is not simply to
Clinical trials are complex by design, but not every delay is caused by the science. Some of the most persistent clinical trial operational bottlenecks develop in the spaces between major milestones: a patient referral that needs additional information, an outreach call that goes unanswered, medical records that have not arrived,
Getting a prescription is not always the same as getting access to treatment. For patients prescribed specialty medications or other complex therapies, the path between a healthcare provider’s treatment decision and the start of therapy can include insurance verification, prior authorization, coverage restrictions, documentation requests, appeals, and questions about out-of-pocket
Serva Health will be exhibiting at DPHARM 2026, taking place September 15 and 16 at the Sheraton Boston. Now in its 16th year, DPHARM brings together more than 1,000 clinical research executives, innovators, patient voices, and technology leaders to explore how clinical trials can become faster, simpler, more accessible, and
Why complex case management and access matters more now For commercial teams, access is no longer a simple sequence of benefits verification, prior authorization, and first dispense. The hardest cases are the ones where patients face multiple barriers at once: restrictive coverage rules, high out-of-pocket costs, specialty pharmacy routing, therapy
The phrase lost to follow-up clinical trials comes up when retention starts to erode, but the damage begins earlier than the final missed visit. Missing outcome data can reduce statistical power, introduce bias, and weaken confidence in treatment effect estimates. In one systematic review of cardiovascular randomized trials in major